Literature DB >> 32839550

The hidden side of PD-L1.

Alison Jaccard1,2, Ping-Chih Ho3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32839550     DOI： 10.1038/s41556-020-0568-y

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  3 in total

Review 1.  Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis.

Authors:  Chin-Lin Guo
Journal:  Front Cell Dev Biol       Date:  2022-06-14

2.  Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment.

Authors:  Rita C Acúrcio; Sabina Pozzi; Barbara Carreira; Marta Pojo; Nuria Gómez-Cebrián; Sandra Casimiro; Adelaide Fernandes; Andreia Barateiro; Vitor Farricha; Joaquim Brito; Ana Paula Leandro; Jorge A R Salvador; Luís Graça; Leonor Puchades-Carrasco; Luís Costa; Ronit Satchi-Fainaro; Rita C Guedes; Helena F Florindo
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

Review 3.  Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy.

Authors:  Erwan Eriau; Juliette Paillet; Guido Kroemer; Jonathan G Pol
Journal:  Cancers (Basel)       Date:  2021-03-12       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.